PV Reporter Facebook Feed

The Latest MPN News with personal commentary, New for 2016!

Facebook Like PV ReporterThe PV Reporter Facebook page is a public, well regarded feed that goes back 100 posts.  So settle in with your favorite beverage, read the latest articles and research reports from leading MPN specialists, patients and other sources.  PV Reporter has maintained a highly informative Facebook page with the most current news stories for 3 years running.  Check it out….you can scroll back to your heart’s content and you may find some shocking revelations!

5 days ago
PV Reporter

One of THE most important and effective combination therapy in MPNs.....No update!
This is not just my thinking (although I'm the perfect candidate to comment, as I'm on the treatment for 2 1/2 years with outstanding results and complete ... See more

***Combo therapy Ruxolitinib and Pegasys, ASH 2015.*** - hot off the press!

LIKE
LOVE
HAHA
WOW
SAD
ANGRY
6 days ago
PharmaEssentia Announces Favorable Two-year Results of Ropeginterferon Alfa-2b in Polycythemia Vera at the American Society of Hematology (ASH) Annual Meeting 2017

PharmaEssentia Announces Favorable Two-year Results of Ropeginterferon Alfa-2b in Polycythemia Vera at the American Society of Hematology (ASH) Annual Meeting ... See more

WALTHAM, Mass., Dec. 10, 2017 /PRNewswire/ -- PharmaEssentia USA, a subsidiary of PharmaEssentia Corporation (Taipei...

LIKE
LOVE
HAHA
WOW
SAD
ANGRY
1 week ago
Phenotypic and Prognostic Relevance of the Who Diagnostic Distinction between Polycythemia Vera and JAK2 -Mutated Essential Thrombocythemia: Combined Analysis of 785 Informative Cases

Phenotypic and Prognostic Relevance of the Who Diagnostic Distinction between Polycythemia Vera and JAK2 -Mutated Essential Thrombocythemia: Combined Analysis of 785 Informative Cases ... See more

Background : The 2016 World Health Organization (WHO) classification system ( Arber et al. Blood 2016;127:2391 ) distinguishes essential thrombocythemia (ET) from polycythemia vera (PV), based primarily on hemoglobin/hematocrit level. However, there ... See more

LIKE
LOVE
HAHA
WOW
SAD
ANGRY
1 week ago
Benefits and pitfalls of Peg-Interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis, a French Intergroup of Myeloproliferative neoplasms (FIM) study

An updated study on the use of Interferon in Myelofibrosis. I will be interviewing one of the chief investigators of this study on Monday - http://www.haematologica.org/content/early/2017/12/01/haematol.2017.181297

We have previously described the safety and efficacy of pegylated interferon-α2a therapy in a cohort of sixty-two patients with myeloproliferative neoplasm-associated myelofibrosis followed in centers affiliated to the French Intergroup of ... See more

LIKE
LOVE
HAHA
WOW
SAD
ANGRY
1 week ago
MPN Heroes Recognition Program | Voices of MPN

I attended the 2017 MPN Heroes Event at the stunning Georgia Aquarium in downtown Atlanta. Ann Brazeau, of MPN Advocacy & Education, did an outstanding job of MCing the event. Here are a few pics of some of the winners...very pleased to see the new ... See more

LIKE
LOVE
HAHA
WOW
SAD
ANGRY
« 1 of 20 »

Check out more resources at MPN Cancer Connection!Click here
error: Content is protected !!